Activist investors have garnered increasing attention, as they try to bend health-care company management to focus on maximizing shareholder value.These proxy fights are important for investors, especially in biotech, where buyouts are the preferred outcome to many holdings.�
The success of Carl Icahn's years-long campaign agitating Forest Labs resulted in a successful takeover by generic drugmaker Actavis. Icahn deservedly crowed about a deal that caused a one-day 28% pop, and ended his time as a shareholder with roughly $1.7 billion in net gains. Investors who jumped in following Icahn's initial investment would have seen three-bagger returns.�
In this segment from Market Checkup, The Motley Fool's health-care focused investing show, analyst David Williamson dives into the activist investor�trend, highlights recent successes and ongoing fights, and explains why investors need to watch this action carefully.
It's no secret that investors tend to be impatient with the market, but the best investment strategy is to buy shares in solid businesses and keep them for the long term. In the special free report, "3 Stocks That Will Help You Retire Rich," The Motley Fool shares investment ideas and strategies that could help you build wealth for years to come. Click here to grab your free copy today.
10 Best Valued Stocks To Invest In 2015: SOHM Inc (SHMN)
SOHM, Inc. is a global generic pharmaceutical manufacturer, developer and marketer having a range of products, covering the therapeutic segments. The Company has its presence in healthcare segments, such as nutraceuticals, dermatology and all other therapeutic segments.
The Company�� generic pharmaceuticals are exported globally with a focus on distribution in Africa, Latin America and Southeast Asia. The Company�� products has presence in analgesic, anti-flammatory, drops, suspensions, vitamins and tonics, antibiotics, beta-lactum antibiotics, injections, syrups, anti-cold, capsules, nutraceutical and tablets.
Advisors' Opinion:- [By Peter Graham]
Small cap stocks VizStar Inc (OTCMKTS: VIZS), SOHM Inc (OTCMKTS: SHMN) and American Soil Technologies, Inc (OTCMKTS: SOYL) have been getting some attention in various investment newsletters with two out of three of these stocks being the subject of paid promotions. However, there is nothing wrong with some paid for attention so long as everything is properly disclosed, but its going to be up to investors and traders alike to ultimately decide whether any of these stocks have what it takes to be the next hot stock. With that in mind, here is a quick reality check about all three small cap stocks:
Top Long Term Stocks To Watch For 2014: MannKind Corporation(MNKD)
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States, Europe, and Asia. Its lead product candidate, AFREZZA Inhalation Powder, an ultra rapid-acting insulin that is in Phase III clinical trials for the treatment of diabetes for the control of hyperglycemia. The company also develops MKC1106-MT, an investigational cancer immunotherapy product, which is in Phase II clinical trials for the treatment of adults with type 1 or type 2 diabetes; and MKC204, which is in preclinical development stage for the treatment of malignancies and inflammatory diseases. In addition, its products include MKC253 (GLP-1), a Phase I clinical trials product for the treatment of type 2 diabetes; MKC1106-PP, a Phase I clinical trials product for diverse tumor types, metastatic disease, and/or progressive and refractory disease; and MKC180, an obesity compound and MKC1106-NS , a cancer immunotherapy product that are in preclinical trials. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.
Advisors' Opinion:- [By Jon C. Ogg]
MannKind Corp. (NASDAQ: MNKD) is a stock that has been on a wild ride for many years. The company’s inhalable insulin has been held up from being approved for years as well. That seems to be coming to a head now, but investors have to understand just how big this game is. It can be a homerun, but it can also be a crusher if the FDA goes against it.
- [By MONEYMORNING.COM]
Since the beginning of the year, MannKind Corp.'s (Nasdaq: MNKD) price per share (PPS) has risen from $5.31 to $9.70 (as I write this), an increase of more than 80%.
- [By Jon C. Ogg]
If you have followed the diabetes drug market for very long, chances are high that you have run across the possibility of an inhalable form of insulin ultimately being approved by the Food & Drug Administration. This is where the controversial company called MannKind Corp. (NYSE: MNKD) comes into play. The company’s stock has traded higher after it has asked the FDA to approve its Afrezza.
- [By Eddie Staley]
Equities Trading DOWN
Shares of MannKind (NASDAQ: MNKD) were down 11.30 percent to $6.28 after the company announced a tentative date of the FDA advisory committee review of AFREZZA.
Top Long Term Stocks To Watch For 2014: BYD Co Ltd (BYDDY)
BYD COMPANY LIMITED is principally engaged in the research, development, manufacture and distribution of automobiles, secondary rechargeable batteries and mobile phone components. The Company operates its businesses primarily through secondary rechargeable battery business, which provides lithium-ion batteries and nickel batteries, which are applied in mobile phones, digital cameras, electric tools, electric toys and other portable electronic devices; mobile phone components and assembly businesses, which offers casings, keypads, liquid crystal display (LCD) modules, cameras, flexible circuit boards, chargers, and mobile phone design and assembly services, as well as automobile business, which provides automobiles, including G6, S6 and other series. Advisors' Opinion:- [By Michael Lewis]
Getty Images Depending on your personal investing philosophy, risk profile, strategy, and a host of external factors, there's a long list of traits you could put on your checklist for what makes a stock right for your portfolio. And then there are the exceptions -- companies that, for good reason, fall outside of the parameters you've set, but that you can't help thinking are a "good investment" But picking a good investment doesn't always have to be so complex. You can use simpler screen -- a checklist of just a few traits that are universally good markers of an appealing long-term holding. Here are three key traits that will key you in to a good investment, regardless of the company's sector, whether it's considered a growth or value stock, or even whether it's a market favorite or a pariah. 1. A brand that's synonymous with the product Technology companies largely rely on human capital for their ongoing competitiveness. Needless to say, people are highly unpredictable assets that can, and do, change quickly. So, products with an Apple logo will only stay popular so long as the mechanics and technology created by its people are cutting-edge. In other words, it's the talent that made Apple (AAPL) what it is today. And in order to remain great, Apple needs to retain its best people and be better than its competitors in acquiring the top minds in its industry. That's why, despite the company's incredible growth and ability to shape the future of multiple industries, Apple will never be as sound an investment as, say, Coca-Cola (KO). Sure, Coca-Cola has an amazing manufacturing and distribution system, along with a super-secret formula to make its signature soft drink. But its true beauty as a company, a brand, and an investment, is that it has taken the simplest of ingredients and through brilliant branding turned its core product into one of the biggest, most recognizable brand names in the world (actually, the third biggest, according to Interbrand's 2013
Top Long Term Stocks To Watch For 2014: Investors Title Company(ITIC)
Investors Title Company, through its subsidiaries, provides title insurance to residential, institutional, commercial, and industrial properties. It underwrites land title insurance for owners and mortgagees as a primary insurer; and offers the reinsurance of title insurance risks to other title insurance companies. The company also provides tax-deferred real property exchange services, as well as serves as an exchange accommodation titleholder and holds property for exchangers in reverse exchange transactions; offers investment management and trust services to individuals, companies, banks, and trusts; and provides consulting services to title insurance agencies. Investors Title Company serves various customers in the residential and commercial market sectors of the real estate industry. It issues title insurance policies primarily through approved attorneys from underwriting offices, as well as through independent issuing agents in 24 states and the District of Columbia, the United States. The company was founded in 1972 and is headquartered in Chapel Hill, North Carolina.
Advisors' Opinion:- [By CRWE]
Investors Title Company (NASDAQ:ITIC), reported its results for the second quarter ended June 30, 2012. Net income increased 110.0% to $3,349,488, or $1.57 per diluted share, compared with $1,594,805, or $0.74 per diluted share, for the prior year quarter.
Top Long Term Stocks To Watch For 2014: Incitec Pivot Ltd (ICPVY)
Incitec Pivot Limited is engaged in the manufacture, trading and distribution of fertilizers, industrial explosives, and chemicals. It operates in two segments: fertilizers, which include Incitec Pivot Fertilisers(IPF), Southern Cross International (SCI), and Fertilisers Elimination (Elim) and explosives, which includes Dyno Nobel Americas (DNA), Dyno Nobel Asia Pacific (DNAP), and Explosives Eliminations (Elim). IPF manufactures products, such as urea, ammonia and single super phosphate. DNA manufactures and sells industrial explosives and related products and services to the mining, quarrying and construction industries and also manufactures agricultural chemicals. SCI manufactures ammonium phosphates and distributes manufactured fertilizer product to wholesaler. DNAP manufactures industrial explosives and related products and services to the mining industry in the Asia Pacific region. In December 2011, it acquired a 49% interest in Maine Drilling Group. Advisors' Opinion:- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- Australian stocks fell early Wednesday, tracking a weak lead from the U.S. but with a few blue-chip miners higher after gains for some commodities overnight. The S&P/ASX 200 (AU:XJO) retreated 0.4% to 5,237.80 after similar losses for the main Wall Street indexes, with the Australian benchmark trading around its lowest level since October. Among the major decliners, Qantas Airways Ltd. (AU:QAN) (QUBSF) lost 2.5%, Harvey Norman Holdings Ltd. (AU:HVN) (HNORY) gave up 1.3%, and Incitec Pivot Ltd. (AU:IPL) (ICPVY) fell 1.8%. Santos Ltd. (AU:STO) (STOSF) fell 2.6% on indication it will miss its lowered production guidance for 2013, according to the Australian Financial Review. On the upside, top miners BHP Billiton Ltd. (AU:BHP) (BHP) and Rio Tinto Ltd. (AU:RIO) (RIO) rose 0.3% and 0.7%, respectively, while Fortescue Metals Group Ltd. (AU:FMG) (FSUMF) traded 1% higher. Shares of global shopping-mall developer Westfield Group Australia (AU:WDC) (WEFIF) were on halt